ACC sent a letter Tuesday to President Trump and all 50 US governors stressing the chemical sector’s need to maintain operations and access critical supplies and transportation systems as extraordinary measures are taken to control the spread of coronavirus disease 2019 (COVID-19).
“While many of these limitations are currently in the best interest of public health, it is essential that key industries and sectors, including the chemical manufacturing sector, are able to maintain operations throughout this challenging time,” said Chris Jahn, ACC president and CEO, in the letter. “Many ACC member companies have instituted telework policies to reduce the number of employees traveling to work and interacting with co-workers. However, the operation of manufacturing plants cannot be done remotely and requires the day-to-day presence of highly trained personnel. This also includes ensuring access to critical supplies and transportation systems so our industry can continue to produce and deliver essential products.”
ACC says it is coordinating with multiple federal agencies, including the Department of Transportation (DOT) and Department of Homeland Security (DHS) to help ensure the continuity of operations and safety of employees.
The chemical industry is fundamental to the continued operation of multiple other sectors, including products and material needed to support infection control and good hygiene, and treat those who are infected with COVID-19 in the weeks and months ahead, Jahn said. Such products include biocides, disinfectants, medical supplies, and personal protective equipment.
By Robert Westervelt
Source: Chemical Week
Lin will become the company’s Chief Transformation and Talent Officer. She will be responsible for Human Resources, Strategy and Business Consulting and drive the accelerated transformation of Bayer.
Johnson Matthey plc (JM; London) has confirmed that its battery cathode materials plant in Konin, Poland, will be powered solely by electricity from renewable sources from day one of production.
Britain’s Oxford University has received a donation of £100 million (112 million euros, $136 million) to research growing resistance to antibiotics, the university announced on Tuesday. The sum, from British chemicals multinational Ineos, is one of the largest donations given to Oxford University in its long history.